Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subhypnotic propofol to prevent post-extubation laryngospasm
IRCT20220206053958N4Phase 3Completed
- Sponsor
- Alborz University of Medical Sciences
- Start
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of propofol in laryngismus, Tonsillar hyperplasia, adenoidal hypertrophy and 2 more, sponsored by Alborz University of Medical Sciences. Started Apr 2026; status: completed.
02
Drugs
propofol
03
Conditions
laryngismusTonsillar hyperplasiaadenoidal hypertrophychronic tonsillitischronic adenoiditis
Beyond the preview
Go deeper on IRCT20220206053958N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220206053958N4.